Vismodegib in Treating Patients With Basal Cell Carcinoma
by on Friday, June 29th, 2012 | No Comments
Conditions: Basal Cell Carcinoma of the Skin; Recurrent Skin Cancer
Interventions: Drug: vismodegib; Procedure: Mohs surgery
Sponsors: Stanford University; Stanford University; National Cancer Institute (NCI)
Recruiting – verified June 2012
Read the original post: Vismodegib in Treating Patients With Basal Cell Carcinoma